GI Research Institute (G.I.R.I.) — Vancouver, British Columbia

Public research footprint of GI Research Institute (G.I.R.I.), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn's Disease · Ulcerative Colitis · Primary Biliary Cholangitis · Obesity or Overweight

Recently updated registry entries

NCT06937099 — Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… (Recruiting)
NCT06937086 — Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With… (Recruiting)
NCT07165028 — A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at GI Research Institute (G.I.R.I.)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.